47
Growth Score in past quarter
pts
Heat Score 47 in past quarter
-18 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
Recent Milestones
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
See more interactive data and historical milestones on desktop for the best experience
629549
Avobis Bio develops investigational implantable cell therapies to treat debilitating conditions.
- Tiffany Johnson Brown: Chief Executive OfficerPast Role: Georgia Institute of Technology, Graduate Research Assistant
About the Company
Avobis Bio develops investigational implantable cell therapies to treat debilitating conditions. The investigational portfolio explores the use of mesenchymal stem cells combined with bioabsorbable scaffolds to improve the effectiveness of cells in stimulating the body to heal.
Avobis Bio was formed as a joint venture between Mayo Clinic and W. L.
Gore & Associates to combine capabilities in clinical care, cell biology, materials science, and commercialization of medical products.